Rhythm Biosciences: Request for quotation of securities – RHY

0

Quotation request for + securities

Summary of the announcement

Name of entity

LIMITED BIOSCIENCE RHYTHM

Type of news

New Listing

Date of this announcement

Thursday 02 December 2021

The + securities to be listed are:

+ Securities issued, transferred or reclassified following the exercise of options or other + convertible securities being converted

Total number of + securities to be listed

ASX + security

Number of + titles to

coded

Security Description

to be quoted

Date of issue

RHY

REGULAR FULLY PAID

1,768

12/02/2021

See the next page for details on the announcement

Quotation request for + securities

1/7

Quotation request for + securities

Part 1 – Entity and Listing Details

1.1 Entity name

LIMITED BIOSCIENCE RHYTHM

We (the entity named above) request + a listing of the following + securities and accept the questions set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ABN

59619459335

1.3

ASX transmitter code

RHY

  1. The announcement is New Listing
  2. Date of this announcement

2/12/2021

Quotation request for + securities

2/7

Quotation request for + securities

Part 2 – Type of problem

2.1 The + securities to be listed are:

+ Securities issued, transferred or reclassified following the exercise of options or other + convertible securities being converted

2.2 The + securities to be listed are:

Additional + titles in a class already listed on the ASX (“existing class”)

Quotation request for + securities

3/7

Quotation request for + securities

Part 3B – number and type of + listed securities (existing category) the issue of which has not been previously notified to the ASX in an appendix 3B

+ existing titles converted into + additional titles in an existing class

DE (existing class)

ASX + security code and description

RHYAK: OPTION EXPIRING 31-AOT-2022 EX $ 1.20

To (existing class)

ASX + security code and description

RHY: ORDINARY FULLY PAID

Please indicate the number of options that have been exercised or other + convertible securities that have been converted

1,028

The first date on which the options were exercised or the other convertible + securities were converted

2/12/2021

The last date of exercise of options or conversion of other + convertible securities

2/12/2021

Are these all options or other convertible + securities issued on issue of this type (i.e. have all these options been exercised or have all these convertible securities now been converted)?

No

The right of the holder of options or other convertible + securities to receive the + underlying securities is satisfied by:

A show of new + titles

The underlying securities received by the holder are:

Intended to be, but not yet, cited by ASX

Have the options been exercised or have other convertible securities been converted as part of an employee profit-sharing plan?

No

Date of issue

2/12/2021

Will the + securities to be listed rank in all respects from their date of issue as the + existing securities issued in this category?

Yes

Quotation request for + securities

4/7

Quotation request for + securities

Details of the problem

Number of + securities to be listed

1,028

Are + securities issued for cash consideration?

Yes

In what currency is the cash consideration paid? What is the issue price per + security?

AUD – Australian Dollar

1.20000000 AUD

Any other information that the entity wishes to provide on the + securities to be listed

+ existing titles converted into + additional titles in an existing class

DE (existing class)

ASX + security code and description

RHYAL: OPTION EXPIRING JUL 31, 2024 $ 1.80

To (existing class)

ASX + security code and description

RHY: ORDINARY FULLY PAID

Please indicate the number of options that have been exercised or other + convertible securities that have been converted

740

The first date on which the options were exercised or the other convertible + securities were converted

2/12/2021

The last date of exercise of options or conversion of other + convertible securities

2/12/2021

Are these all options or other convertible + securities issued on issue of this type (i.e. have all these options been exercised or have all these convertible securities now been converted)?

No

The right of the holder of options or other convertible + securities to receive the + underlying securities is satisfied by:

A show of new + titles

The underlying securities received by the holder are:

Intended to be, but not yet, cited by ASX

Have the options been exercised or have other convertible securities been converted as part of an employee profit-sharing plan?

No

Quotation request for + securities

5/7

This is an excerpt from the original content. To continue reading it, access the original document here.

Disclaimer

Rhythm Biosciences Ltd. published this content on 02 December 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 02 December 2021 05:30:07 AM UTC.

Public now 2021

All the news on RHYTHM BIOSCIENCES LIMITED
Sales 2022

Net income 2022 -7.30M
-5.19 million
-5.19 million
Net cash 2022 1.70 million
1.21 million
1.21 million
PER 2022 ratio -51.2x
Yield 2022
Capitalization 363 million
260 million
259 million
VE / Sales 2022
VE / Sales 2023 16.8x
Number of employees
Free float 53.4%

RHYTHM BIOSCIENCES LIMITED Chart
Duration :

Period:

Rhythm Biosciences Limited Technical Analysis Chart |  MarketScreener

Technical analysis trends RHYTHM BIOSCIENCES LIMITED

Short term Mid Road Long term
Tendencies Neutral Bullish Bullish

Evolution of the income statement

To sell

To buy

Average consensus TO BUY
Number of analysts 0
Last closing price

1.74

Average price target
Spread / Average target


Source link

Share.

Comments are closed.